compounded tirzepatide update (GLP-1/GIP) FDA Allows Compounded Tirzepatide During

Proper preparation and storage help ensure consistent, reliable results in long-term studies.

Chewing food into smaller particles also reduces the mechanical work your stomach needs to do, potentially speeding up the emptying process even under GLP-1 influence

According to Novo Nordisk, Wegovy has demonstrated the ability to achieve a 20 percent or greater weight reduction in at least one in three patients, when used alongside lifestyle interventions such as a reduced-calorie diet and increased physical activity

Its active ingredient, Semaglutide, reduces appetite and slows the rate at which food leaves the stomach, resulting in lower calorie intake and gradual weight reduction over time